NCT00118456View on ClinicalTrials.gov

Study of Oral AEE788 in Adults With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

January 31, 2008

Conditions
Cancer
Interventions
DRUG

AEE788

Trial Locations (5)

37203

Sarah Cannon Research Institute, Nashville

77054

MD Anderson Cancer Center, Houston

78229

Institute of Drug Development/Cancer Therapy and Research Center, San Antonio

89125

Nevada Cancer Institute, Las Vegas

06520

Yale Cancer Center, New Haven

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY